Elrexfio 44 mg/1.1 ml, Injektionslösung

7680686460010 CH-68646 Injektionslösung
Elrexfio 44 mg/1.1 ml, Injektionslösung
Elrexfio 44 mg/1.1 ml, Injektionslösung
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/09/2025
Summary of Product Characteristics
Français
26/09/2025
Summary of Product Characteristics
Italien
26/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
44.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.0074 MG Substance HBESI

Reimbursement information

Public price
CHF 3125.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2024

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
68646
Drug name
Elrexfio, Injektionslösung
Galenic form
LSINJ
ATC Code
L01F
Authorization status
B
Dispensing category
A
First authorization
05/09/2023
Authorization expiration date
30/06/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Multiples Myelom

Package details

Description (FR)
ELREXFIO sol inj 44 mg/1.1ml flac 1.1 ml
Description (DE)
ELREXFIO Inj Lös 44 mg/1.1ml Durchstf 1.1 ml
Market launch
05/09/2023
Narcotic (BTM)
No

Other package sizes (1)

ELREXFIO sol inj 76 mg/1.9ml flac 1.9 ml
1 DUR
GTIN: 7680686460027
View